IHTC NEWS:
09.11.2010 - Sickle Cell-abration 2010
The IHTC is sponsoring a free concert to raise awareness of sickle cell disease! Come and enjoy a diverse blend of music at the Madame Walker Theater. The free concert is from 5 to 9 pm; doors open at 4:30 pm. You may also choose to share the gift of life with those who have sickle cell disease by...
04.20.2010 - IHTC voted one of Indiana's best workplaces!
As reported in the IndyStar, over 600 companies in central Indiana were invited by Workplace Dynamics of Exton, PA, to participate in a workplace survey in January 2010. Nearly 20,000 employees from 101 large, middle, and small companies voted on their workplace management,...
Conditions We Treat
Conditions We Treat
The IHTC cares for individuals affected by a wide variety of hematologic conditions. Some of the most common disorders that are cared for through the IHTC include the following conditions:
- Bleeding Disorders:
- Hemophilia: The prevalence of hemophilia is approximately 1 in every 5,000 male births. Approximately 30% of newly diagnosed cases have no family history of hemophilia. Female carriers of this disorder may have levels that place them in the mild range of deficiency and may require intermittent treatment.
- Von Willebrand Disease: The prevalence of Von Willebrand disease is estimated to approach 1 to 2 individuals per 100 in the general population. Males and females are equally affected.
- Clotting Disorders:
- Thrombosis is defined as abnormal or excessive clotting.
- Thrombophilia: Thrombophilia or hypercoagulability is the tendency to develop a blood clot due to an underlying abnormality in the coagulation system. Inherited defects in one or more of the clotting factors can lead to development of potentially dangerous blood clots. Approximately 5% to 8% of the US population, up to 20 million individuals nationwide, is estimated to be affected by one of these clotting disorders. Collectively these conditions are referred to as thrombophilia, where a genetic or acquired defect can be identified that may result in thrombosis. Most affected individuals develop thrombosis only in the presence of an additional risk factor. There is no specific treatment for most thrombophilias, but recurrent episodes of thrombosis may be an indication for long-term preventative anticoagulation or represent a need for prophylactic anticoagulation in high-risk clinical circumstances.
- Factor V Leiden: Factor V Leiden is the most common inherited thrombophilic risk factor and affects approximately 5% to 7% of the white population in the United States.
- Thrombosis is defined as abnormal or excessive clotting.
- Other Inherited Blood Disorders:
- Sickle Cell Disease: Sickle cell disease occurs in approximately 1 in every 400 African Americans and also affects people of other ethnic backgrounds. Sickle cell disease is an abnormality of the hemoglobin, the substance that carries oxygen in the red blood cell. Although sickle cell disease is an abnormality of the hemoglobin, the clinical problems associated with this disorder are multisystem requiring comprehensive, knowledgeable caregivers.
- Additional Conditions we Treat:The IHTC cares for a wide variety of hematologic disorders including, but not limited to, disorders of red and white blood cells, platelets and bone marrow.
